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Introduction
Th e goal of our project has been to establish human 
organoid/enteroid cultures as a preclinical model to 
study the pathophysiology of non-inﬂ ammatory (small 
intestinal) diarrheas and inﬂ ammatory diarrhea models 
as well as to develop drug therapy. Th e rate-limiting step 
in translational research is often the absence of reliable 
preclinical models that adequately reﬂ ect relevant human 
physiology and disease pathophysiology. Moreover, drug 
development based on in vitro cell culture and/or animal 
models often fails in clinical trials due to ineﬀ ectiveness 
and/or signiﬁ cant side eﬀ ects. Since detailed studies of 
the contributions of speciﬁ c transport proteins to normal 
intestinal water and electrolyte homeostasis have not 
been accomplished in human intestine, one cause of 
these failures that must be considered is that diﬀ erences 
may exist between humans and other model systems in 
the expression, localization and/or regulation of proteins 
that are important for normal intestinal transport or that 
become abnormal as part of the pathophysiology of 
diarrhea. Th ere is thus an urgent need to develop and 
validate novel preclinical models of human diseases in 
general.
Th is need is particularly true in the ﬁ eld of human 
diarrheal diseases, which cause ~4% of all deaths 
worldwide, including 1.2  million deaths in children per 
year, and are a leading cause of death in the aged 
population in the USA [1]. Th e morbidity/mortality 
caused by diarrhea is due to abnormal regulation of ion 
and water transport across the intestinal epithelium 
leading to signiﬁ cant dehydration. Th e goal of therapy is 
to rehydrate the patient either using transport processes 
not aﬀ ected by the diarrheal disease (the concept on 
which oral rehydration solutions were developed) or by 
restoring normal intestinal electrolyte transport. In all 
diarrheal diseases there is reduced Na+ absorption 
primarily due to inhibition of the brush border Na+/H+
exchanger NHE3 and perhaps the Cl–/HCO3– exchanger 
DRA, while in enterotoxigenic diarrheas there is 
additional stimulation of anion secretion via the cystic 
ﬁ brosis transmembrane conductance regulator (CFTR) 
[2,3]. Unfortunately, over the past 35  years the 
approaches to correct this abnormal intestinal ion 
transport in diarrhea have failed to produce any 
signiﬁ cant drug for treating diarrhea to supplement the 
use of oral rehydration solution-based therapy, which is 
currently used in only ~33% of children with severe 
diarrhea in developing countries [1].
Approach
A human intestinal model that duplicates normal physio-
logic salt and water transport and is reproducible and 
readily available is needed as part of the strategy for drug 
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development for diarrheal diseases. In developing such a 
model, consideration must be given to segmental diﬀ er-
ences along the horizontal axis of the gastrointestinal 
tract that relate to diﬀ erent transport proteins being 
represented, as well as to regulation of those transporters 
by the local neuroendocrine environment, which is 
relevant to regulation of multiple transport processes [4]. 
Components of the microbiome that are present 
luminally also are likely to inﬂ uence this regulation. 
Transport proteins are attractive drug targets that likely 
require consideration of developmental stages, so a 
system to duplicate diﬀ erences in transport protein 
expression across infant, adult, and aged populations 
would be useful. Another potential barrier for drug 
development in diarrheal diseases relates to the presence 
of polymorphisms, epigenetic modiﬁ  cations and 
diﬀ erences in drug metabolism in individual patients, an 
area that has led to the concept of personalized medicine.
Recent progress in the identiﬁ cation and isolation of 
human intestinal epithelial stem cells has led to the 
creation ex vivo of three-dimensional small intestinal 
epithelial functional units called intestinal organoids and 
enteroids that include the entire villus–crypt axis and all 
epithelial cell types normally present. Two techniques 
using human intestinal stem cells have been reported 
[5-7]. One starts with human pluripotent stem cells (H9 
or others; WiCell International Stem Cell Bank, Madison, 
WI, USA) that diﬀ eren tiate into organoid cultures which 
contain multiple cell types, including enterocytes, goblet 
cells, enteroendo crine cells, Paneth cells and mesen-
chymal cell popu lations. Th e second technique starts 
with whole intestinal crypts isolated from adult human 
intestinal tissue (surgery or biopsies) and includes only 
epithelial cells, Paneth cells, goblet cells and entero-
endocrine cells (ex pres sion of M cells requires additional 
culture conditions [8]) but does not contain mesenchymal 
elements. Th e develop ment of these enteroids was 
pioneered by the ground breaking studies of Hans 
Clevers and his coworkers in Utrecht, the Netherlands, 
who identiﬁ ed the intestinal stem cell as one expressing 
Lgr5 [9] and established the conditions needed to initiate 
small and large intestinal enteroid growth and long-term 
culture, as well as the conditions to induce diﬀ erentiation 
[5,10]. Th e approaches to grow enteroids are very recent 
and modiﬁ cations have been reported [11-13].
Using Clevers’ methods, we have been establishing 
human enteroids as a model to understand the physio-
logic control of intestinal water and electrolyte transport, 
including changes that occur in digestion and become 
exaggerated in diarrheal diseases. Recently, Dekkers and 
colleagues demonstrated in human enteroids derived 
from rectal biopsies that forskolin-induced luminal 
dilation can serve as a functional assay to measure CFTR 
function [14]. Models presently established in our 
labora tories include enteroids from the human 
duodenum, jejunum, ileum and proximal colon. Studies 
have been initiated to characterize them as regards: 
polarity; expression of transport proteins involved in 
intestinal Na+ absorption and Cl– secretion, including 
expression along the horizontal axis of the intestine and 
along the villus–crypt axes under normal conditions and 
in disease; comparison with intact human tissue 
concerning locali zation of transport proteins and 
polarization markers along vertical and horizontal axes 
of the intestine; ability to freeze these ex vivo preparations 
as well as to re-establish the cultures from the frozen 
specimens; maintenance of functional characteristics 
over multiple passages; interaction with luminal bacteria 
and viruses as components of the human microbiome; 
and genetic and epigenetic diversity.
Th e enteroids were obtained from endoscopic biopsies 
from subjects felt to have no organic intestinal pathology 
after endoscopy and surgical specimens that otherwise 
would have been discarded, which is enabling establish-
ment of an enteroid bank. Th is will facilitate consider-
ation of biologic diversity among human subjects in 
terms of all parameters to be studied. Th ese enteroids are 
polarized, based on localization of known apical (villin), 
basolateral membrane (Na+/K+-ATPase) markers, and 
tight junction morphology using immunoﬂ uorescence 
and transmission electron microscopy (Figure  1). Th e 
enteroids express transport proteins that take part in Na+ 
absorption and anion secretion similar to normal human 
intestine along the horizontal and vertical axes of the 
intestine. NHE3, DRA, SGLT1 and CFTR are expressed 
apically, while Na+/K+-ATPase and NKCC1 are localized 
to the basolateral membrane; SGLT1 is present in the 
duodenum and jejunum, minimally expressed in the 
ileum, and absent in the proximal colon. Th e enteroids 
also express Ca2+-activated Cl– channels and K+ channels. 
Although enteroids do not form ﬂ at monolayers in this 
particular culture system, ion transport activity can be 
measured in intact three-dimensional cultures. Regula-
tion of Na+ absorption and Cl– secretion in the enteroids 
occur as in human intestine, with forskolin inhibiting 
NHE3 and stimulating Cl– secretion by activating CFTR 
(Figure  2). Th is regulation mimics what occurs in the 
human jejunum in the early postprandial period.
Besides their relevance for understanding human intes-
tinal physiology, the enteroids serve as an excellent model 
of human enteric infections. We previously showed that 
organoids are susceptible to infection with rotavirus [15] 
and we have now evaluated the use of enteroids to study 
rotavirus infectivity and replication. Jejunal enteroids 
established from tissues of patients undergoing bariatric 
surgery can support rotavirus replication, as conﬁ rmed 
by detection of nonstructural viral proteins by immuno-
ﬂ uorescence (Figure 3a) and increased levels of viral RNA 
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by quantitative RT-PCR (Figure 3b). Th e nonstructural 
viral proteins, NSP4 and NSP5, show the expected 
punctate staining patterns, representing viroplasms, the 
sites of virus replication and particle assembly. Th ese 
results demonstrate the ability to com pare rotavirus 
infection and replication in organoids and enteroids, and 
demonstrate that the enteroids may be useful to study 
pathogenesis of multiple enteric pathogens.
Conclusion
Th ese studies have been initiated recently, and while 
enteroid culture and initial functional studies have been 
achieved, further goals in the study of pathophysiology of 
diarrhea must consider two factors. First, one must 
consider the pathogenesis of diarrhea in neural regulation 
of intestinal Na+ absorption and Cl– secretion, given that 
Figure 1. Cells within human enteroids refl ect morphology of 
native intestinal tissue. (a) Human enteroids are well polarized, 
expressing apical villin (green) and basolateral Na+/K+-ATPase (red). 
Nuclei are indicated by Hoescht 33342 (blue). (b) Transmission 
electron microscopy demonstrates presence of intact tight junctions. 
n = 3 for each experiment.
Figure 2. Human enteroids recapitulate two major functions 
of the small intestine: Na+ absorption and Cl– secretion. 
(a) Enteroids exhibit NHE3 activity, which can be inhibited by 
forskolin (FSK) treatment before or after initiation of transport 
measurements. Diff erentiated enteroids were loaded with the 
pH-sensitive dye SNARF-4F and prepulsed with 50 mM NH4Cl to 
acidify the cytosol. Na+-dependent alkalinization in the presence 
of 50 μM HOE694 is due to NHE3 activity (no alkalinization in 
the presence of the NHE3 inhibitor S3226, added after HOE694). 
n = 6 for each condition. CTL, control; STD, pH standards; TMA, 
tetramethylammonium chloride. (b) Duodenal enteroid lumens 
(L) signifi cantly dilate in response to elevated cAMP levels via FSK 
treatment. After FSK treatment, the size of enteroid lumens increased 
203 ± 16% over controls. The same optical section of enteroids 
loaded with SNARF-4F was compared before (red) and after (green) 
30 minutes of FSK treatment. Arrows indicate change in position of 
epithelial layer due to luminal dilation. n = 3 for each experiment.
Figure 3. Human jejunal enteroids support rotavirus growth. 
(a) Nonstructural viral proteins, NSP4 (green) and NSP5 (red), were 
detected in enteroids by confocal microscopy. Basolateral membrane 
marked by E-cadherin (purple) and nuclei (blue) by 4’,6-diamidino-
2-phenylindole (DAPI) staining. (b) GAPDH-normalized rotavirus 
VP7 RNA levels are shown as fold increases relative to 0 hours post 
infection. Values are means of triplicates and standard deviation for 
three amplifi cations per sample.
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~50% of several severe diarrheas (cholera toxin-induced 
and rotavirus diarrhea) are neurally mediated [16,17]. 
Th e second factor to consider is the role of diﬀ erentiation 
of the enteroids in the expression level and localization of 
transport proteins and their physiologic and patho-
physio logic regulation. Future studies will also evaluate 
changes in expression of key transport proteins following 
infection as well as establishing methods to evaluate drug 
eﬀ ects on normal and infected cultures, including those 
grown as monolayers [18].
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